STAT

A spot of good news in an Ebola crisis: Vaccine supplies are expected to last

There’s some good news related to an Ebola outbreak that has offered very little up till now.
Nurses working with the World Health Organization prepare to administer vaccines in Mbandaka in the Democratic Republic of the Congo.

There’s some good news related to an Ebola crisis that has offered very little up until now. The World Health Organization now predicts there are adequate supplies of an experimental Ebola vaccine to control the outbreak in the Democratic Republic of the Congo.

“I believe we will have enough vaccine to stop this outbreak unless something very dramatic changes,” Dr. Peter Salama, WHO’s deputy director-general of emergency preparedness and response, told STAT.

And while an ongoing clinical trial of the vaccine may not be complete

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks